Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 634

1.

Hepatitis C in Arkansas: updates on epidemiology, testing and treatment.

Beebe A, Quattlebaum T, Gicquelais RE, Zohoori N, Haselow DT, Smith NH.

J Ark Med Soc. 2015 May;111(12):248-51.

PMID:
25966598
2.

Duplicate hepatitis C antibody testing in New York City, 2006-2010.

Tsai V, Bornschlegel K, McGibbon E, Arpadi S.

Public Health Rep. 2014 Nov-Dec;129(6):491-5.

PMID:
25364050
3.

Seronegative occult hepatitis C virus infection: clinical implications.

Carreño V.

J Clin Virol. 2014 Nov;61(3):315-20. doi: 10.1016/j.jcv.2014.09.007. Epub 2014 Sep 28. Review.

PMID:
25304062
4.

Unrecognized chronic hepatitis C virus infection among baby boomers in the emergency department.

Galbraith JW, Franco RA, Donnelly JP, Rodgers JB, Morgan JM, Viles AF, Overton ET, Saag MS, Wang HE.

Hepatology. 2015 Mar;61(3):776-82. doi: 10.1002/hep.27410. Epub 2015 Jan 28.

PMID:
25179527
5.

Follow-up testing for hepatitis C virus infection: an analysis of Massachusetts surveillance data, 2007-2010.

Barton K, Church D, Onofrey S, Cocoros N, DeMaria A Jr.

Public Health Rep. 2014 Sep-Oct;129(5):403-7.

PMID:
25177051
6.

[A preliminary assessment of the clinical utility of measuring hepatitis C virus antibody to evaluate infection status].

Long L, Liu Y, Duan Z, Xu Q, Shen T, Dou X, Zhuang H, Lu F.

Zhonghua Gan Zang Bing Za Zhi. 2014 Apr;22(4):244-50. doi: 10.3760/cma.j.issn.1007-3418.2014.04.002. Chinese.

PMID:
25173220
7.

High prevalence of hepatitis markers in immigrant populations: a prospective screening approach in a real-world setting.

Heidrich B, Cetindere A, Beyaz M, Stahmeyer JT, Basaran MM, Braynis B, Raupach R, Bremer B, Manns MP, Wedemeyer H, Bastürk M.

Eur J Gastroenterol Hepatol. 2014 Oct;26(10):1090-7. doi: 10.1097/MEG.0000000000000164.

PMID:
25076065
8.

Screening tests for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus in blood donors: evaluation of two chemiluminescent immunoassay systems.

Sommese L, Sabia C, Paolillo R, Parente D, Capuano M, Iannone C, Cavalca F, Schiano C, Vasco M, De Pascale MR, Casamassimi A, Napoli C.

Scand J Infect Dis. 2014 Sep;46(9):660-4. doi: 10.3109/00365548.2014.926564. Epub 2014 Jul 30.

PMID:
25073538
9.

Multiple liver lesions in a patient with positive hepatitis C serology and elevated AFP: is it HCC?

Dwyer JP, Hosking P, Lubel J.

Gastroenterology. 2014 Sep;147(3):e12-3. doi: 10.1053/j.gastro.2014.04.051. Epub 2014 Jul 23. No abstract available.

PMID:
25064545
10.

Hepatitis C: the next 25years.

Houghton M.

Antiviral Res. 2014 Oct;110:77-8. doi: 10.1016/j.antiviral.2014.06.018. Epub 2014 Jul 17.

PMID:
25043637
11.

Hepatitis C virus screening practices and seropositivity among US veterans born during 1945 - 1965.

Cartwright EJ, Rentsch C, Rimland D.

BMC Res Notes. 2014 Jul 14;7:449. doi: 10.1186/1756-0500-7-449.

12.

[The diagnosis of hepatitis C virus infection].

Gervain J.

Orv Hetil. 2014 Jun 29;155(26):1019-23. doi: 10.1556/OH.2014.29972. Review. Hungarian.

PMID:
24954143
13.

Hepatitis C virus core antigen testing: role in diagnosis, disease monitoring and treatment.

Tillmann HL.

World J Gastroenterol. 2014 Jun 14;20(22):6701-6. doi: 10.3748/wjg.v20.i22.6701. Review.

14.

Understanding the presence of false-positive antibodies in acute hepatitis.

Sakiani S, Koh C, Heller T.

J Infect Dis. 2014 Dec 15;210(12):1886-9. doi: 10.1093/infdis/jiu348. Epub 2014 Jun 18.

PMID:
24943727
15.

Review: Occult hepatitis C virus infection: still remains a controversy.

Vidimliski PD, Nikolov I, Geshkovska NM, Dimovski A, Rostaing L, Sikole A.

J Med Virol. 2014 Sep;86(9):1491-8. doi: 10.1002/jmv.23979. Epub 2014 Jun 4. Review.

PMID:
24895180
16.

Impact of isolated hepatitis C virus (HCV) core-specific antibody detection and viral RNA amplification among HCV-seronegative dialysis patients at risk for infection.

Barril G, Quiroga JA, Arenas MD, Espinosa M, García-Fernández N, Cigarrán S, Herrero JA, del Peso G, Caro P, García-Agudo R, Amézquita Y, Blanco A, Martínez-Rubio P, Alcázar JM, González-Parra E, Martín-Gómez A, Castillo I, Bartolomé J, Carreño V.

J Clin Microbiol. 2014 Aug;52(8):3053-6. doi: 10.1128/JCM.01339-14. Epub 2014 May 21.

17.

Trends in hepatitis C virus infections among MSM attending a sexually transmitted infection clinic; 1995-2010.

Urbanus AT, Van De Laar TJ, Geskus R, Vanhommerig JW, Van Rooijen MS, Schinkel J, Heijman T, Coutinho RA, Prins M.

AIDS. 2014 Mar 13;28(5):781-90. doi: 10.1097/QAD.0000000000000126.

PMID:
24832014
18.

Performance of rapid hepatitis C virus antibody assays among high- and low-risk populations.

Scalioni Lde P, Cruz HM, de Paula VS, Miguel JC, Marques VA, Villela-Nogueira CA, Milagres FA, Cruz MS, Bastos FI, Andrade TM, Motta-Castro AR, Lewis-Ximenez LL, Lampe E, Villar LM.

J Clin Virol. 2014 Jul;60(3):200-5. doi: 10.1016/j.jcv.2014.04.001. Epub 2014 Apr 13.

PMID:
24794796
19.

Performance of the OraQuick HCV rapid antibody test for screening exposed patients in a hepatitis C outbreak investigation.

Gao F, Talbot EA, Loring CH, Power JJ, Dionne-Odom J, Alroy-Preis S, Jackson P, Bean CL.

J Clin Microbiol. 2014 Jul;52(7):2650-2. doi: 10.1128/JCM.00132-14. Epub 2014 Apr 30.

20.

Comparison of two diagnostic algorithms for the identification of patients with HCV viremia using a new HCV antigen test.

Reyes-Méndez MÁ, Juárez-Figueroa L, Iracheta-Hernández P, Medina-Islas Y, Ruiz-González V.

Ann Hepatol. 2014 May-Jun;13(3):337-42.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk